External links
Models for profile: MA0524.2
Models for profile: MA0814.2
25 datasets found for the same TF (TFAP2C) in other cell-types/tissues
| TF Name | Cell-line | Condition/Source | Collections | Species | Identifiers | JASPAR ID |
|---|---|---|---|---|---|---|
| TFAP2C | HeLa S3 (cervical adenocarcinoma) | None | Permissive Robust | Homo sapiens | wgEncodeEH000686 | MA0524.2 ... |
| TFAP2C | WA09 (embryonic stem cells) | BMP4 for 3 day | Permissive Robust | Homo sapiens | GSE105081 ... | MA0814.2 ... |
| TFAP2C | WA09 (embryonic stem cells) | BMP4 for 3 day | Permissive | Homo sapiens | GSE105081 ... | MA0524.2 ... |
| TFAP2C | WA09 (embryonic stem cells) | BMP4 for 3 day | Permissive Robust | Homo sapiens | GSE105081 ... | MA0524.2 ... |
| TFAP2C | UCLA1 hESCs | PasNumber:p16+ p37; Treatment: Naive(5iLAF) conditions; | Permissive Robust | Homo sapiens | GSE101074 ... | MA0524.2 ... |
| TFAP2C | UCLA1 hESCs | PasNumber:p16+ p37; Treatment: Naive(5iLAF) conditions; | Permissive Robust | Homo sapiens | GSE101074 ... | MA0524.2 ... |
| TFAP2C | UCLA1 hESCs | PasNumber:p16+ p37; Treatment: Naive(5iLAF) conditions; | Permissive Robust | Homo sapiens | GSE101074 ... | MA0524.2 ... |
| TFAP2C | UCLA1 hESCs | PasNumber: p33; Treatment: 5 days in 5iLAF; | Permissive Robust | Homo sapiens | GSE101074 ... | MA0524.2 ... |
| TFAP2C | UCLA1 hESCs | PasNumber: p28; CellType: Prime UCLA1 hESSCs; | Permissive Robust | Homo sapiens | GSE101074 ... | MA0524.2 ... |
| TFAP2C | UCLA1 hESCs | PasNumber: p28; CellType: Prime UCLA1 hESSCs; | Permissive Robust | Homo sapiens | GSE101074 ... | MA0524.2 ... |
| TFAP2C | UCLA1 hESCs | PasNumber: p28; CellType: Prime UCLA1 hESSCs; | Permissive Robust | Homo sapiens | GSE101074 ... | MA0524.2 ... |
| TFAP2C | UCLA1 hESCs | PasNumber: p52; Genotype: TFAP2C -/-; Treatment: No Induc; | Permissive | Homo sapiens | GSE101074 ... | MA0524.2 ... |
| TFAP2C | UCLA1 hESCs | PasNumber: p52; Genotype: TFAP2C -/-; Treatment: transduced construct that allows doxycycline inducible expression of TFAP2C; | Permissive Robust | Homo sapiens | GSE101074 ... | MA0524.2 ... |
| TFAP2C | UCLA1 hESCs | PasNumber: p52; Genotype: TFAP2C -/-; Treatment: transduced construct that allows doxycycline inducible expression of TFAP2C; | Permissive Robust | Homo sapiens | GSE101074 ... | MA0524.2 ... |
| TFAP2C | MCF7 (Invasive ductal breast carcinoma) | Treatment: with Estrogen +1,6-Hexanediol; | Permissive Robust | Homo sapiens | GSE117492 ... | MA0524.2 ... |
| TFAP2C | A375 (malignant melanoma) | DMSO | Permissive Robust | Homo sapiens | GSE41234 | MA0524.2 ... |
| TFAP2C | ZHBTc4-TS (trophoblast stem cells) | Permissive Robust | Mus musculus | GSE51511 ... | MA0524.2 ... | |
| TFAP2C | mammary tumor | Permissive Robust | Mus musculus | GSE61394 ... | MA0524.2 ... | |
| TFAP2C | MCF7 (Invasive ductal breast carcinoma) | Permissive Robust | Homo sapiens | GSE21234 | MA0524.2 ... | |
| TFAP2C | BT-474 (breast invasive ductal carcinoma) | Permissive Robust | Homo sapiens | GSE36351 | MA0524.2 ... | |
| TFAP2C | MCF7 (Invasive ductal breast carcinoma) | Permissive Robust | Homo sapiens | GSE36351 | MA0524.2 ... | |
| TFAP2C | MDA-MB-453 (breast adenocarcinoma) | Permissive Robust | Homo sapiens | GSE36351 | MA0524.2 ... | |
| TFAP2C | SK-BR-3 (breast adenocarcinoma) | Permissive Robust | Homo sapiens | GSE36351 | MA0524.2 ... | |
| TFAP2C | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive Robust | Homo sapiens | GSE23852 | MA0524.2 ... |
| TFAP2C | MCF7 (Invasive ductal breast carcinoma) | ETOH | Permissive Robust | Homo sapiens | GSE23852 | MA0524.2 ... |